Oxford Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Oxford Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-40,953	Closed	-$918K	–	2007
2018 Q1	$918K	Buy	+40,953	New	+$999K	0.02%	976
2016 Q4	–	Sell	-42,329	Closed	-$827K	–	910
2016 Q3	$827K	Sell	42,329 -167,264	-80%	-$2.83M	0.03%	553
2016 Q2	$3.14M	Buy	+209,593	New	+$2.63M	0.1%	259
2016 Q1	–	Sell	-99,441	Closed	-$1.9M	–	944
2015 Q4	$1.9M	Buy	+99,441	New	+$1.73M	0.04%	412

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Oxford Asset Management's FLXN Position: Q2 2018 in Review

Oxford Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2018, closing a stake of 40,953 shares — an estimated $918K sold.

Oxford Asset Management first reported a position in FLXN in Q4 2015 and held it in 4 quarters. The position peaked at $3.14M in Q2 2016. 130 funds tracked by Wall St. Rank hold FLXN as of Q2 2018.

Oxford Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Oxford Asset Management sold 40,953 Flexion Therapeutics, Inc. shares in Q2 2018, an estimated $918K.
Oxford Asset Management first reported a position in Flexion Therapeutics, Inc. in Q4 2015 and held it in 4 quarters.
Oxford Asset Management's Flexion Therapeutics, Inc. position peaked at $3.14M in Q2 2016.
130 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2018.

Based on Oxford Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.